Lantern Pharma Statistics Share Statistics Lantern Pharma has 10.78M
shares outstanding. The number of shares has increased by 0.19%
in one year.
Shares Outstanding 10.78M Shares Change (YoY) 0.19% Shares Change (QoQ) 0% Owned by Institutions (%) 22.47% Shares Floating 8.16M Failed to Deliver (FTD) Shares 4,405 FTD / Avg. Volume 1.79%
Short Selling Information The latest short interest is 548.97K, so 5.09% of the outstanding
shares have been sold short.
Short Interest 548.97K Short % of Shares Out 5.09% Short % of Float 5.78% Short Ratio (days to cover) 1
Valuation Ratios PE Ratio 0 Forward PE -2.54 PS Ratio 0 Forward PS 23.9 PB Ratio 0 P/FCF Ratio -1.93 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Lantern Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.01,
with a Debt / Equity ratio of 0.
Current Ratio 0.01 Quick Ratio 0.01 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-865.88M Employee Count 24 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 12.18% in the
last 52 weeks. The beta is 1.59, so Lantern Pharma's
price volatility has been higher than the market average.
Beta 1.59 52-Week Price Change 12.18% 50-Day Moving Average 3.7 200-Day Moving Average 3.71 Relative Strength Index (RSI) 65.68 Average Volume (20 Days) 246,585
Income Statement
Revenue n/a Gross Profit n/a Operating Income -22.22B Net Income -20.78B EBITDA -20.59M EBIT -20.78M Earnings Per Share (EPS) -1930.92
Full Income Statement Balance Sheet The company has 7.51M in cash and 243.66K in
debt, giving a net cash position of 7.27M.
Cash & Cash Equivalents 7.51M Total Debt 243.66K Net Cash 7.27M Retained Earnings -76.03B Total Assets 21.1M Working Capital 16.54M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -17.81M
and capital expenditures -12.6K, giving a free cash flow of -17.83M.
Operating Cash Flow -17.81M Capital Expenditures -12.6K Free Cash Flow -17.83M FCF Per Share -1.66
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
